These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35688630)

  • 1. Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis.
    Wandall-Holm MF; Buron MD; Kopp TI; Thielen K; Sellebjerg F; Magyari M
    J Neurol Neurosurg Psychiatry; 2022 Aug; 93(8):858-864. PubMed ID: 35688630
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies.
    Spelman T; Magyari M; Piehl F; Svenningsson A; Rasmussen PV; Kant M; Sellebjerg F; Joensen H; Hillert J; Lycke J
    JAMA Neurol; 2021 Oct; 78(10):1197-1204. PubMed ID: 34398221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis.
    Chalmer TA; Buron M; Illes Z; Papp V; Theodorsdottir A; Schäfer J; Hansen V; Asgari N; Skejø PB; Jensen HB; Sørensen PS; Magyari M
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):67-74. PubMed ID: 31727727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.
    Brenner P; Alexanderson K; Björkenstam C; Hillert J; Jokinen J; Mittendorfer-Rutz E; Tinghög P
    PLoS One; 2014; 9(8):e104165. PubMed ID: 25093730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
    Vandhuick O; Payet M; Préaud E; Lortet-Tieulent J; Raguideau F; Chevreuil O; van Hille B; Kwiatkowski A
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1135-1144. PubMed ID: 34165377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol consumption and risk of unemployment, sickness absence and disability pension in Denmark: a prospective cohort study.
    Jørgensen MB; Thygesen LC; Becker U; Tolstrup JS
    Addiction; 2017 Oct; 112(10):1754-1764. PubMed ID: 28544338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of multiple sclerosis and labour-force absenteeism: a longitudinal population-based study.
    Castelo-Branco A; Landfeldt E; Svedbom A; Löfroth E; Kavaliunas A; Hillert J
    Eur J Neurol; 2019 Apr; 26(4):603-609. PubMed ID: 30414299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis.
    McKay KA; Friberg E; Razaz N; Alexanderson K; Hillert J
    JAMA Neurol; 2021 Apr; 78(4):478-482. PubMed ID: 33616605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term impact of early treatment of multiple sclerosis on the risk of disability pension.
    Landfeldt E; Castelo-Branco A; Svedbom A; Löfroth E; Kavaliunas A; Hillert J
    J Neurol; 2018 Mar; 265(3):701-707. PubMed ID: 29392457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Socioeconomic risk indicators for disability pension within the Danish workforce. A registry-based cohort study of the period 1994-1998].
    Brun C; Bøggild H; Eshøj P
    Ugeskr Laeger; 2003 Aug; 165(35):3315-9. PubMed ID: 14531369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
    Amato MP; Fonderico M; Portaccio E; Pastò L; Razzolini L; Prestipino E; Bellinvia A; Tudisco L; Fratangelo R; Comi G; Patti F; De Luca G; Brescia Morra V; Cocco E; Pozzilli C; Sola P; Bergamaschi R; Salemi G; Inglese M; Millefiorini E; Galgani S; Zaffaroni M; Ghezzi A; Salvetti M; Lus G; Florio C; Totaro R; Granella F; Vianello M; Gatto M; Di Battista G; Aguglia U; Logullo FO; Simone M; Lucisano G; Iaffaldano P; Trojano M
    Brain; 2020 Oct; 143(10):3013-3024. PubMed ID: 32935843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
    Scalfari A; Neuhaus A; Degenhardt A; Rice GP; Muraro PA; Daumer M; Ebers GC
    Brain; 2010 Jul; 133(Pt 7):1914-29. PubMed ID: 20534650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employment, disability pension and income for children with parental multiple sclerosis.
    Moberg JY; Laursen B; Koch-Henriksen N; Thygesen LC; Brødsgaard A; Soelberg Sørensen P; Magyari M
    Mult Scler; 2017 Jul; 23(8):1148-1156. PubMed ID: 27682230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
    He A; Merkel B; Brown JWL; Zhovits Ryerson L; Kister I; Malpas CB; Sharmin S; Horakova D; Kubala Havrdova E; Spelman T; Izquierdo G; Eichau S; Trojano M; Lugaresi A; Hupperts R; Sola P; Ferraro D; Lycke J; Grand'Maison F; Prat A; Girard M; Duquette P; Larochelle C; Svenningsson A; Petersen T; Grammond P; Granella F; Van Pesch V; Bergamaschi R; McGuigan C; Coles A; Hillert J; Piehl F; Butzkueven H; Kalincik T;
    Lancet Neurol; 2020 Apr; 19(4):307-316. PubMed ID: 32199096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social consequences of multiple sclerosis: clinical and demographic predictors - a historical prospective cohort study.
    Pfleger CC; Flachs EM; Koch-Henriksen N
    Eur J Neurol; 2010 Nov; 17(11):1346-51. PubMed ID: 20402759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smokers' increased risk for disability pension: social confounding or health-mediated effects? Gender-specific analyses of the Hordaland Health Study cohort.
    Haukenes I; Riise T; Haug K; Farbu E; Maeland JG
    J Epidemiol Community Health; 2013 Sep; 67(9):758-64. PubMed ID: 23709663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
    Shirani A; Zhao Y; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Gustafson P; Petkau J; Tremlett H
    JAMA; 2012 Jul; 308(3):247-56. PubMed ID: 22797642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study.
    Jørgensen H; Horváth-Puhó E; Laugesen K; Brækkan S; Hansen JB; Sørensen HT
    PLoS Med; 2021 Aug; 18(8):e1003770. PubMed ID: 34464405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.